US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Call Them About A Specific Blood Test To Determine A Failure-Don’t Get Left Holding The Bag
The US Drug Watchdog says, "We are urging recipients of a DePuy Pinnacle metal on metal hip implant to get a specific blood test designed to measure for elevated levels of cobalt, and chromium, and to call us at 866-714-6466 for specific instructions about the blood test, and the steps needed to make sure they are copied on the test. Once they get the blood test results we will have them reviewed by independent medical experts to establish if the cobalt, or chromium levels are elevated." http://USDrugWatchdog.com
(PRWEB) July 19, 2013
The US Drug Watchdog says, "We do not want one recipient of a DePuy Pinnacle metal on metal hip implant left holding the bag with tens of thousands of dollars in medical bills, if we can determine this specific type of metal on metal hip implant has already failed-via a very simple blood test. Just call us at 866-714-6466, we will give the specific name of the blood test we want you to get, and we will provide you with simple instructions to ensure you get a copy of the blood test results. If the hip implant recipients blood test reveals elevated levels of cobalt, or chromium we will get you to national caliber law firms that will get you identified to the court handling the litigation over the DePuy Pinnacle metal on metal hip implant, and premature failures." According to court records there are DePuy Pinnacle all metal hip implant recipients in all US states including California, New York, Florida, Texas, Ohio, Pennsylvania, Massachusetts, Maine, Rhode Island, North Carolina, Kentucky, Tennessee, Georgia, Alabama, Louisiana, Mississippi, Missouri, Maryland, Michigan, Iowa, Indiana, Illinois, Wisconsin, Minnesota, North Dakota, Kansas, South Dakota, Nebraska, New Mexico, Colorado, Utah, Idaho, Arizona, Nevada, Oregon, and Washington. For more information recipients of a DePuy Pinnacle metal on metal hip implant are urged to contact the US Drug Watchdog, for more information about a simple blood test designed to see if this specific type of metal on metal hip implant has failed.
The US Drug Watchdog indicates symptoms of a DePuy Pinnacle metal on metal hip implant failure include:
- Pain in the Hip Region
- Problems While Walking or The Inability to Walk
- Swelling of the Hip
- General Discomfort
- Lack of Flexibility
- Elevated levels of cobalt, or chromium in the hip implant recipients blood.
The US Drug Watchdog is the premier medical device, and pharmaceutical watchdog in the United States. The group says, “We want to make certain all DePuy Pinnacle hip implant recipients get a blood test to determine if their hip implant has failed. In the event the blood test indicates elevated levels of cobalt, and chromium we will get the recipient to national caliber law firms that have a superior record in representing their clients in these types of national lawsuits, involving potentially significant financial compensation." For more information about the DePuy Pinnacle metal on metal hip implant, and a critical blood test please contact the US Drug Watchdog anytime at 866-714-6466. http://USDrugWatchdog.com
U.S. District Court for the Northern District of Texas MDL#2244
Urgent Notice: The US Drug Watchdog says, "The statute of limitations on the recalled DePuy ASR metal on metal hip implant has not yet run out in the following states: Arkansas, Washington D.C., Florida, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Rhode Island, South Carolina, South Dakota, Vermont, Washington, Wisconsin, and Wyoming. If you are a recipient of a recalled DePuy ASR, and you have not yet been identified by the court please call us as soon as immediately at 866-714-6466, if the procedure was done in one of these states." http://USDrugWatchdog.Com
DePuy ASR Case Number Ohio Southern Federal District Court Case Number MDL # 2197
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/7/prweb10896843.htm